Pyridoxal kinase (PdxK) from S. typhimurium was cloned, purified and crystallized. Successful structure solution was accomplished in spite of strong polycrystalline noise in the oscillation images.
Keywords: pyridoxal kinase, Salmonella typhimurium
Abstract
Pyridoxal kinase (PdxK; EC 2.7.1.35) belongs to the phosphotransferase family of enzymes and catalyzes the conversion of the three active forms of vitamin B6, pyridoxine, pyridoxal and pyridoxamine, to their phosphorylated forms and thereby plays a key role in pyridoxal 5′-phosphate salvage. In the present study, pyridoxal kinase from Salmonella typhimurium was cloned and overexpressed in Escherichia coli, purified using Ni–NTA affinity chromatography and crystallized. X-ray diffraction data were collected to 2.6 Å resolution at 100 K. The crystal belonged to the primitive orthorhombic space group P212121, with unit-cell parameters a = 65.11, b = 72.89, c = 107.52 Å. The data quality obtained by routine processing was poor owing to the presence of strong diffraction rings caused by a polycrystalline material of an unknown small molecule in all oscillation images. Excluding the reflections close to powder/polycrystalline rings provided data of sufficient quality for structure determination. A preliminary structure solution has been obtained by molecular replacement with the Phaser program in the CCP4 suite using E. coli pyridoxal kinase (PDB entry 2ddm) as the phasing model. Further refinement and analysis of the structure are likely to provide valuable insights into catalysis by pyridoxal kinases.
1. Introduction
Pyridoxal 5′-phosphate (PLP) is the most active form of vitamin B6 and functions as a cofactor for a large number of enzymes involved in amino-acid metabolism (Toney, 2005 ▶). In the PLP salvage pathway, pyridoxal kinase (PK) catalyzes the ATP-dependent conversion of three vitamin B6 precursors, pyridoxal (PL), pyridoxamine (PMN) and pyridoxine (PN), to their phosphorylated forms (di Salvo et al., 2011 ▶). Crystal structures of pyridoxal kinase are known from human (Musayev et al., 2007 ▶), Trypanosoma brucei (Jones et al., 2012 ▶), sheep brain (Li et al., 2002 ▶), Escherichia coli (Safo et al., 2004 ▶), Bacillus subtilis (Newman et al., 2006 ▶) and Lactobacillus plantarum (PDB entry 3h74; New York SGX Research Center for Structural Genomics, unpublished work). In E. coli, two genes, pdxK and pdxY, code for pyridoxal kinase (Yang et al., 1996 ▶, 1998 ▶; Safo et al., 2006 ▶).
In the present study, we have initiated structural and biochemical investigations on Salmonella typhimurium pyridoxal kinase (StPK). In this paper, we describe the cloning, overexpression, crystallization and preliminary structure determination of StPK. X-ray diffraction images obtained by oscillation photography contained nearly continuous rings of strong spots resulting from an unidentified contaminating polycrystalline material. Processing these images with iMosflm v.1.0.7 from the CCP4 suite led to poor data statistics and the data obtained were not optimal for structure determination. Exclusion of reflections on or near the unwanted rings could be accomplished in a number of ways, either before or after integration of the images. For example, MOSFLM allows exclusion of all data within user-specified resolution ranges. We used a pre-release version of iMosflm that makes use of this MOSFLM feature to avoid integrating reflections close to the unwanted diffraction rings. The quality of the data thus obtained was significantly better and led to successful structure determination.
2. Materials and methods
2.1. Cloning, overexpression and purification
The pyridoxal kinase gene (pdxK; STM2435) coding for 288 amino-acid residues was PCR-amplified from the Salmonella enterica serovar typhimurium strain LT2 genomic DNA using specific sense (CCCCATATGATGGGACAAGAGAGTGATATTCAGTC) and antisense (CCCCTCGAGTCGCGCCTCCCCTGCCGGCAG) primers. The bold sequences in the sense and antisense primers represent restriction sites for NdeI and XhoI, respectively. PCR involved initial denaturation at 371 K (1 min), 30 cycles of denaturation at 371 K (30 s), annealing at 329 K (30 s) and elongation at 345 K (1 min) and the final extension was at 345 K (10 min). The PCR-amplified product was digested with NdeI and XhoI and ligated into the vector pET-22b(+) (Novagen) previously digested with the same restriction enzymes. The positive clone (pET22b-PK) obtained was further confirmed by DNA sequencing. The recombinant construct thus obtained had an extra methionine at the N-terminus and eight residues (LEHHHHHH) at the C-terminus that included a hexahistidine tag. The presence of the hexahistidine tag facilitated purification of StPK by Ni–NTA affinity chromatography.
The recombinant pET22b-StPK plasmids were transformed into E. coli BL21 (DE3) pLysS competent cells for overexpression. An LB agar plate containing 50 µg ml−1 ampicillin was used to select the transformants. A single colony was used to prepare a pre-inoculum and 5 ml of it was transferred to 500 ml of LB medium containing 50 µg ml−1 ampicillin. The culture was grown at 310 K until the OD600 reached 0.6. Overexpression of StPK was induced by the addition of 0.3 mM IPTG. The culture was incubated at 303 K for 5–6 h post-induction. SDS–PAGE examination revealed the overexpression of a protein corresponding to the expected molecular weight of ∼32 kDa. The cells were pelleted by centrifugation at 5855g in a GSA rotor for 10 min at 277 K. The recovered cells were suspended in 50 mM potassium phosphate pH 7.5, 0.1 M NaCl, 10%(v/v) glycerol and lysed by sonication at 277 K. Cell debris was removed by centrifugation at 12 857g in an SS34 rotor at 277 K for 40 min. The supernatant was collected and the expressed protein was allowed to bind Ni–NTA beads equilibrated with extraction buffer (50 mM potassium phosphate pH 7.5, 0.1 M NaCl) on an end-to-end rotor for 3 h at 277 K. The Ni–NTA beads were loaded onto a column. Nonspecifically bound proteins were washed from the column using extraction buffer containing 20 mM imidazole. StPK was then eluted from the column using 200 mM imidazole in extraction buffer at 277 K. The eluted protein was concentrated using a 30 kDa molecular-weight cutoff Centricon (Amicon). 1 ml concentrated protein was loaded onto a Superdex S-200 preparative column previously equilibrated with 20 mM potassium phosphate pH 7.5, 1 mM EDTA and eluted with the same buffer at 277 K. Peak fractions which corresponded to the dimeric form of the protein were pooled, concentrated to 15 mg ml−1 and used for crystallization. The protein concentration was estimated by measuring the OD at 280 nm and using the calculated molar extinction coefficient obtained from the ProtParam server (Wilkins et al., 1999 ▶). This method of purification provided 15–20 mg ml−1 of protein per litre of cell culture. The purity of the eluted protein was also ascertained by SDS–PAGE (Fig. 1 ▶).
Figure 1.

Purification profile of StPK. Lane 1, molecular-weight markers (labelled in kDa); lane 2, Ni–NTA eluted protein; lane 3, protein after gel filtration.
2.2. Crystallization and data collection
Initial trials of StPK crystallization were carried out using microbatch as well as hanging-drop vapour-diffusion methods at 293 K. Various conditions were screened using commercially available kits from Hampton Research and Jena Bioscience. Each crystallization droplet consisted of 2 µl protein solution at 15 mg ml−1 and 2 µl crystallization condition. In the hanging-drop vapour-diffusion method, crystallization droplets were placed over 400 µl reservoir solution. In the microbatch method, a 1:2 mixture of silicone and paraffin oils was layered over droplets consisting of 2 µl protein solution and 2 µl crystallization cocktail. Crystals (Fig. 2 ▶) were obtained at 293 K by the microbatch method from a condition (Jena Bioscience Basic 2/A3) consisting of 20%(w/v) PEG 4000, 10%(v/v) 2-propanol, 100 mM HEPES pH 7.5 in 10–15 d after setting up crystallization. These crystals were used for data collection. No hits were obtained in the hanging-drop method of crystallization.
Figure 2.

A typical crystal of S. typhimurium pyridoxal kinase.
Cu Kα radiation (λ = 1.5418 Å) generated by a rotating-anode X-ray generator (Rigaku RU200) was used for X-ray diffraction data collection. The X-ray beam was focused using Osmic mirror optics and the images were recorded using a MAR Research image-plate (MAR345) detector system. Data collection was carried out at 100 K with a 1.0° oscillation angle and an exposure time of 300 s per frame. The crystal-to-detector distance was maintained at 200 mm. The crystal was soaked in crystallization condition containing 20% ethylene glycol as the cryoprotectant for 5 min prior to data collection. The crystal diffracted to 2.6 Å resolution as shown in Fig. 3 ▶.
Figure 3.
An oscillation image obtained from a crystal of StPK illustrating strong polycrystalline noise rings at ∼3.14, 2.74 and 2.43 Å resolutions.
3. Results
3.1. Data processing and structure determination
The diffraction data were processed using iMosflm 1.0.7 (Battye et al., 2011 ▶; Leslie, 2006 ▶) and scaled using SCALA (Evans, 2006 ▶) from the CCP4 program suite (Winn et al., 2011 ▶). Autoindexing indicated that the crystal belonged to the orthorhombic system, with unit-cell parameters a = 65.11, b = 72.89, c = 107.52 Å. Further analysis of systematic absences using the program POINTLESS in the CCP4 suite (Evans, 2006 ▶; Winn et al., 2011 ▶) suggested that the crystal belonged to space group P212121. The crystal asymmetric unit was compatible with two monomers (calculated Matthews coefficient of 1.99 Å3 Da−1; Matthews, 1968 ▶). The data quality was poor as indicated by the R merge and other parameters (Table 1 ▶). Attempts to determine the structure by molecular replacement using E. coli PK (PDB entry 2ddm, chain A; Safo et al., 2006 ▶) as the phasing model, with which StPK shares 68% amino-acid sequence identity, were unsuccessful. It was observed that the oscillation images had a few rings of strong spots owing to diffraction by some polycrystalline material. The resolution of these rings corresponded to ∼3.14, 2.74 and 2.43 Å. Ice or crystals of salts that were present in the crystallization cocktail do not cause rings at these resolutions. A pre-release version of the iMosflm graphical user interface (GUI) became available for processing the data in a CCP4 workshop held at the Okinawa Institute of Science and Technology, Okinawa, Japan on 4–8 November 2013. This new version of the iMosflm GUI can make use of a feature long available in MOSFLM to exclude reflections close to polycrystalline rings from integration. This version of iMosflm has now been released as iMosflm 7.1.0. The quality of the data obtained after the exclusion of rings was substantially higher, although the data completeness was reduced by almost 10%. Table 1 ▶ provides a comparison of the results of processing with the old and the pre-release versions of iMosflm. The decrease in overall completeness (90.1%) obtained with the pre-release version of iMosflm is due to the deletion of a large number of reflections in shells around 3.14 and 2.74 Å corresponding to the observed polycrystalline rings. However, the highest resolution shell is not close to any polycrystalline ring and hence its completeness is nearly 100%. With the new data, a reasonable initial structure could be determined by molecular replacement using E. coli PK as the phasing model in Phaser (McCoy et al., 2007 ▶) from the CCP4 suite, with RFZ, TFZ and LLG scores of 4.6, 18.1 and 868, respectively. Rigid-body refinement followed by restrained refinement of positional parameters with REFMAC5 (Murshudov et al., 2011 ▶) from the CCP4 suite resulted in R and R free values of 30.74 and 36.99%, respectively. The corresponding values for the data obtained using the earlier version of iMosflm were 47.66 and 51.90%, respectively. A cartoon representation of the structure superposed on E. coli PK is depicted in Fig. 4 ▶. Further refinement and model building are in progress. A detailed analysis of the structure and its implications for the mechanism of enzymatic function will be published elsewhere.
Table 1. Data-collection, processing and initial refinement statistics.
Values in parentheses are for the highest resolution shell.
| Data set obtained with iMosflm 1.0.7 | Data set obtained with the pre-release version of iMosflm (now iMosflm 7.1.0) | |
|---|---|---|
| Wavelength (Å) | 1.54 | 1.54 |
| Crystal-to-detector distance (mm) | 200.3 | 200.3 |
| Rotation range per image (°) | 1 | 1 |
| Exposure time per image (s) | 300 | 300 |
| Resolution range (Å) | 72.73–2.60 (2.74–2.60) | 72.89–2.60 (2.74–2.60) |
| Space group | P212121 | P212121 |
| Unit-cell parameters (Å) | a = 65.25, b = 72.73, c = 107.56 | a = 65.11, b = 72.89, c = 107.52 |
| Mosaicity (°) | 1.5 | 1.5 |
| Total No. of measured intensities | 86565 (11999) | 81619 (12715) |
| Unique reflections | 16029 (2276) | 14688 (2278) |
| Multiplicity | 5.4 (5.3) | 5.6 (5.6) |
| Mean I/σ(I) | 6.0 (3.0) | 9.9 (3.5) |
| Completeness (%) | 98.6 (97.9) | 90.1 (98.1) |
| R merge † (%) | 23.7 (50.6) | 13.6 (48.5) |
| R meas ‡ (%) | 26.4 (84.0) | 15.1(53.4) |
| Rigid-body refinement | ||
| R work § (%) | 50.32 | 44.01 |
| R free ¶ (%) | 51.20 | 44.28 |
| Initial restrained refinement | ||
| R work § (%) | 47.66 | 30.74 |
| R free ¶ (%) | 51.90 | 36.99 |
R
merge =
.
R
meas =
, where Ii(hkl) is the intensity of the ith observation of reflection hkl, 〈I(hkl)〉 is its mean intensity and N(hkl) is the number of measurements (redundancy).
R
work (%) =
, where F
obs and F
calc are observed and calculated structure factors, respectively.
R free (%) is calculated as for R work but for a randomly selected 5% of the data set excluded from the refinement process.
Figure 4.

A cartoon representation of the preliminary structure of StPK (orange) superposed on E. coli PK (green).
4. Discussion
In this work, PK from S. typhimurium was purified to homogeneity and crystallized, and X-ray diffraction data were collected using X-rays from an in-house rotating-anode generator. The crystals belonged to space group P212121 with two protomers in the asymmetric unit. Structure determination by molecular replacement using the corresponding E. coli enzyme as the phasing model should have been straightforward because of the high (68%) amino-acid sequence identity between the model and the target structures. However, an acceptable solution to the structure could not be obtained. It was apparent that rings of strong spots appearing on all oscillation images owing to a polycrystalline contaminant were the reason for the poor quality of the scaled diffraction data and perhaps also for the difficulty in structure determination. A pre-release version of iMosflm that can avoid spots close to specified diffraction rings was used for integration of the images. This helped to improve the data quality in a significant way. Structure determination using the data obtained with the new version of iMosflm was straightforward. Interestingly, it was possible to process the oscillation frames with the old version of iMosflm to a limited resolution of 3.2 Å so that integration of reflection intensities is avoided in the resolution rings containing polycrystalline spots and obtain a data set that could be used successfully for structure determination and refinement. The results presented in this paper illustrate in an interesting way the well recognized importance of the processing strategy and data quality in X-ray crystal structure analysis.
Acknowledgments
The X-ray facility at the Molecular Biophysics Unit, Indian Institute of Science was used to collect the intensity data. MRNM and HSS acknowledge the Department of Science and Technology (DST) and the Department of Biotechnology (DBT), Government of India, for financial support. FB was supported by a Kothari post-doctoral fellowship. GD thanks Fadel Samatey for inviting her to the CCP4 School held at Okinawa Institute of Science and Technology, Japan and Phil Evans for helping her in processing the data set.
References
- Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. W. (2011). Acta Cryst. D67, 271–281. [DOI] [PMC free article] [PubMed]
- di Salvo, M. L., Contestabile, R. & Safo, M. K. (2011). Biochim. Biophys. Acta, 1814, 1597–1608. [DOI] [PubMed]
- Evans, P. (2006). Acta Cryst. D62, 72–82. [DOI] [PubMed]
- Jones, D. C., Alphey, M. S., Wyllie, S. & Fairlamb, A. H. (2012). Mol. Microbiol. 86, 51–64. [DOI] [PMC free article] [PubMed]
- Leslie, A. G. W. (2006). Acta Cryst. D62, 48–57. [DOI] [PubMed]
- Li, M.-H., Kwok, F., Chang, W.-R., Lau, C.-K., Zhang, J.-P., Lo, S. C. L., Jiang, T. & Liang, D.-C. (2002). J. Biol. Chem. 277, 46385–46390. [DOI] [PubMed]
- Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. [DOI] [PubMed]
- McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007). J. Appl. Cryst. 40, 658–674. [DOI] [PMC free article] [PubMed]
- Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367. [DOI] [PMC free article] [PubMed]
- Musayev, F. N., di Salvo, M. L., Ko, T. P., Gandhi, A. K., Goswami, A., Schirch, V. & Safo, M. K. (2007). Protein Sci. 16, 2184–2194. [DOI] [PMC free article] [PubMed]
- Newman, J. A., Das, S. K., Sedelnikova, S. E. & Rice, D. W. (2006). J. Mol. Biol. 363, 520–530. [DOI] [PubMed]
- Safo, M. K., Musayev, F. N., di Salvo, M. L., Hunt, S., Claude, J. B. & Schirch, V. (2006). J. Bacteriol. 188, 4542–4552. [DOI] [PMC free article] [PubMed]
- Safo, M. K., Musayev, F. N., Hunt, S., di Salvo, M. L., Scarsdale, N. & Schirch, V. (2004). J. Bacteriol. 186, 8074–8082. [DOI] [PMC free article] [PubMed]
- Toney, M. D. (2005). Arch. Biochem. Biophys. 433, 279–287. [DOI] [PubMed]
- Wilkins, M. R., Gasteiger, E., Bairoch, A., Sanchez, J. C., Williams, K. L., Appel, R. D. & Hochstrasser, D. F. (1999). Methods Mol. Biol. 112, 531–552. [DOI] [PubMed]
- Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
- Yang, Y., Tsui, H.-C. T., Man, T.-K. & Winkler, M. E. (1998). J. Bacteriol. 180, 1814–1821. [DOI] [PMC free article] [PubMed]
- Yang, Y., Zhao, G. & Winkler, M. E. (1996). FEMS Microbiol. Lett. 141, 89–95. [DOI] [PubMed]

